Target intelligence / Profile preview

AZGP1 pseudogene 1 (AZGP1P1)

Target: AZGP1P1
Molecular classification: Other (pseudogene; not a protein-coding gene or molecular family such as receptor, enzyme, etc.)

Overview

AZGP1 pseudogene 1 (AZGP1P1) is a human DNA sequence classified as a pseudogene, highly homologous to the functional AZGP1 gene that encodes zinc-alpha-2-glycoprotein. Pseudogenes typically arise through duplication or mutation of functional genes and often retain sequence similarity but lack protein-coding ability due to disruptive mutations or premature stop codons. There is no evidence supporting AZGP1P1 as a protein-coding gene, nor as a direct molecular target in therapy or disease biology. Current databases and available literature primarily discuss AZGP1P1 in the context of gene structure and homology, rather than molecular function or clinical relevance.

Other names: AZGP1 pseudogene 1AZGP1P1

Mechanism of action

None documented.

Biological functions

None established; pseudogenes typically do not encode functional proteins. Occasional regulatory functions are possible but not widely recognized or structured for AZGP1P1

Disease associations

None directly established for AZGP1P1; disease roles and biomarkers are described for its parent gene AZGP1, mainly in cancer and metabolic disorders, but these do not apply directly to AZGP1P1

Safety considerations

None established; pseudogenes are not therapeutic targets.

Interacting drugs

None known or reported; pseudogenes do not interact with drugs.

Biomarkers

None; AZGP1 itself has biomarker relevance, but AZGP1P1 does not

Beyond the preview

Go deeper on AZGP1 pseudogene 1 (AZGP1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AZGP1 pseudogene 1 (AZGP1P1).

Explore the full profile